Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001193125-25-121717
Filing Date
2025-05-16
Accepted
2025-05-16 16:28:34
Documents
1

Document Format Files

Seq Description Document Type Size
1 DEFA14A d933158ddefa14a.htm DEFA14A 27057
  Complete submission text file 0001193125-25-121717.txt   28180
Mailing Address 490 ARSENAL WAY, SUITE 200 WATERTOWN MA 02472
Business Address 490 ARSENAL WAY, SUITE 200 WATERTOWN MA 02472 (857) 760-0900
Neumora Therapeutics, Inc. (Filer) CIK: 0001885522 (see all company filings)

EIN.: 844367680 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-41802 | Film No.: 25959716
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)